Anti-CCP in systemic lupus erythematosus patients: A cross sectional study in Brazilian patients

Clinical Rheumatology

Volumn 32, Issue 7, 2013, Pages 1065-1070

  Skare, Thelma L ^a   Nisihara, Renato ^b   Barbosa, Bruno Bandolin ^a   Da Luz, Alvaro ^a   Utiyama, Shirley ^b   Picceli, Vanessa ^b  

^a HOSPITAL UNIVERSITÁRIO EVANGÉLICO DE CURITIBA   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Anti CCP; Autoantibodies; Rhupus; Systemic lupus erythematosus

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; BRAZIL; CLINICAL FEATURE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ELISA KIT; HUMAN; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; X RAY;

ADOLESCENT; ADULT; ANTIBODIES; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; BRAZIL; CITRULLINE; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FOOT; HAND; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PEPTIDES, CYCLIC; PREVALENCE; RIBONUCLEOPROTEINS; X-RAYS; YOUNG ADULT;

EID: 84880167262     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2213-7     Document Type: Conference Paper

References (36)

1. Di Cesare PE, Valle CJD, Zuckerman JD (2004) Articular manifestations of Systemic lupus erythematosus. In: Lahita RG (ed) Systemic lupus erythematosus. Elsevier, San Diego, pp 1037-1063
2. Aitcheson CT, Peebles C, Joslin F, Tan EM (1980) Characteristics of antinuclear antibodies in rheumatoid arthritis. Arthritis Rheum 23:528-537
3. De La Torre IG, Miranda-Mendez L (1982) Studies of antinuclear antibodies in rheumatoid arthritis patients. J Rheumatol 42:603-606 (Pubitemid 13205182)
4. Caspi D, Elkayan O, Eisinger M, Vardinon N, Yaron M, Burke M (2001) Clinical significance of low titer antinuclear antibodies in early rheumatoid arthritis: implications on the presentation and long term course of the disease. Rheumatol Int 20:43-47 (Pubitemid 33779811)
5. Quismoro FP (1993) Other serologic abnormalities in SLE. In: Wallace DJ, Hahn B (eds) Dubois systemic lupus erythematosus. Lea & Febiger, Philadelphia, pp 264-276
6. Ioan-Facsinay A, Willemze A, Robinson DB, Peschken CA, Markland J, Van der Woude D et al (2008) Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum 58:3000-3008
7. Lee AN, Beck CE, Hall M (2008) Rheumatoid factor and anti-CCP antibodies in rheumatoid arthritis: a review. Clin Lab Sci 21:15-18
8. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S et al (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146:797-808 (Pubitemid 351650500)
9. Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65:845-851
10. Singh U, Singh S, Singh NK, Verma PK, Singh S (2011) Anti cyclic citrullinated peptide autoantibodies in systemic lupus erythematosus. Rheumatol Int 31:765-767
11. Zhao Y, Li J, Li X, Li L, Li Z (2009) What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus? Joint Bone Spine 76:501-507
12. Qing Y-F, Zhang Q-B, Zhou J-G, Yuan G-H, Wei J, Xing Y et al (2009) The detecting and clinical value of anti cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus. Lupus 18:713-717
13. Kakumanu P, Sobel ES, Narain S, Akaogi J, Yamasaki Y, Segal MS et al (2009) Citrulline dependence of anti cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis. J Rheumatol 36:2682-2690
14. Damian-Abrego GN, Cabiedes J, Cabral AR (2008) Anti citrullinated peptide antibodies in lupus patients with or without deforming arthropathy. Lupus 17:300-304 (Pubitemid 351655797)
15. Mediwake R, Isenberg DA, Schellekens GA, van Venrooij WJ (2001) Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 60:67-68 (Pubitemid 32038957)
16. Taraborelli M, Inverardi F, Fredi M, Ceribelli A, Cavazzana I, Tincani A, Franceschini F (2012) Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? Reumatismo 64:321-325
17. Hochberg MC (1997) Updating the American college of Rheumatology revised criteria for systemic lupus erythematosus. Arthritis Rheum 40:1725
18. Goeldner I, Skare TL, de Messias Reason IT, Nisihara RM, Silva MB, Utiyama SR (2010) Anti-Cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil. Rheumatology 49:1590-1593
19. Fox RI (1997) Sjögren's syndrome. Controversies and progress. Clin Lab Med 17:431-444
20. Marinez JB, Valero JS, Bautista AJ, Restrepo JF, Matteson EL, Rondon F et al (2007) Erosive arthropathy: clinical variance in lupus erythematosus and association with anti CCP case series and review of the literature. Clin Exp Rheumatol 25:47-53 (Pubitemid 46477485)
21. Skare TS, Nisihara RM, Silva RM, Munhoz da Silva DJ, Gameiro Silva MB, Utiyama SR (2011) Anti-cyclic citrullinated peptide antibodies in adult patients with juvenile idiopathic arthritis. Clin Rheumatol 17:421-423
22. Polimeni M, Feniman D, Skare TS, Nisihara RM (2012) Anticyclic citrullinated peptide antibodies in scleroderma patients. Clin Rheumatol 31:877-880
23. Alenius GM, Berglin E, Dalqvist SR (2006) Antibodies against cyclic cytrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis 65:398-400 (Pubitemid 43268233)
24. Senkpiehl I, Marget M, Wedler M, Jenisch S, Georgi J et al (2005) HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis. Int Arch Allergy Immunol 137:315-318 (Pubitemid 41161023)
25. Kakumanu P, Sobel ES, Narain S, Jun UL, Akogi K, Yamasaki Y et al (2009) Citrulline dependence of anti cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis. J Rheumatol 36:2682-2690
26. Panush RS, Edwards NL, Longley S, Webster E (1988) Rhupus syndrome. Arch Intern Med 148:1633-6
27. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, Van der Horst-Bruinsma IE, de Kpning MH et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50:380-386 (Pubitemid 38198821)
28. Majka DS, Deane KD, Parrish LA, Lazar AA, Barón AE, Walker CM et al (2008) Duration of preclinical RA-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann Rheum Dis 67:801-807 (Pubitemid 351829380)
29. Chibnik LB, Mandi LA, Costendaber KH, Shur PH, Karlson EW (2009) Comparison of threshold cut-points and continuous measures of anti-CCP antibodies in predicting future RA. J Rheumatol 36:706-711
30. Lee DM, Pjillips R, Hagan EM, Chibnik LB, Costenbader KH, Shur PH (2009) Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis 68:201-208
31. Cavazzana I, Francheschini F, Quinzanini M, Manera C, Del Papa N, Maglione W et al (2006) Anti Ro/SS-A antibodies in rheumatoid arthritis. Clinical and immunological associations. Clin Exp Rheumatol 24:59-64
32. Franchescini F, Cavazzana L (2005) Anti-Ro/SSA and La/SSB antibodies. Autoimmunity 38:55-63 (Pubitemid 40515004)
33. Schneeberger E, Citera G, Heredia M, Cocco JM (2008) Clinical significance of anti- Ro antibodies in rheumatoid arthritis. Clin Rheumatol 27:517-519
34. Zanlorenzi L, Azevedo LOP, Silva MB, Skare TL (2012) Anti-Ro in rheumatoid arthritis. Acta Rheum Port 37:149-151
35. Mohammed K, Pope J, Riche N, Brintnell W, Cairns E, Coles R et al (2009) Association of severe inflammatory polyarthritis in primary sjögren's syndrome: clinical, serological and HLA analysis. J Rheumatol 36:1937-1942
36. Verpoort KN, van Gaalen FA, Mil AHMH, Schreuder GMT, Breedveld FCM, Huizinga TWJ et al (2005) Association of HLA-DR3 with anti cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum 52:3058-3062 (Pubitemid 41447086)